None listed
Conditions
Interventions
Others(AUL NiacinGold™ Sun Screen) : The test site was located on the subject's back, avoiding the spine and any areas with skin discoloration or lesions. A total of 20 µL of the test product was appl
Sponsors
Human Co., Ltd. Skin Clinical Trial Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Male and female adults over the age 19 years old - Subjects who have sensitive and hypersensitive skin - Subjects who signed consent form voluntarily after being sufficiently informed regarding the objectives of study and all related contents - Subjects who are healthy without acute and chronic diseases including skin disorders - Subjects who can be observed and traced throughout the entire study period
Exclusion criteria
Exclusion criteria: - Subjects who is pregnant or breast-feeding - Subject who has psychiatric disease and infectious skin disease - Subject who has skin lesion on the test site such as moles, pimples, erythema, scalds (burns), hemotelangiosis, and scars - Subject who has atopic skin disease - Subject who has used skin ointment containing steroid on the test site for more than one month - Subject who has irritation history or allergy to adhesive tape - Subject who has been part of the same clinical trial within the past 3 months - Subject who is on contraceptive, anti-histamine and anti-inflammatory prescriptions - Subject who has cosmetics or sunlight allergies - Employee in this clinical trial center - Anyone who is considered non-qualified by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| skin primary irritation | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of skin adverse reaction | — |
Countries
Korea, Republic of
Contacts
Public ContactKim Hyein
Human Co., Ltd. Skin Clinical Trial Center
Outcome results
None listed